We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
Trial record 12 of 181 for:    "autosomal recessive cerebellar ataxia type 1" OR "Cerebellar Ataxia"

Virtual Reality-based Training in Cerebellar Ataxia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02900508
Recruitment Status : Completed
First Posted : September 14, 2016
Last Update Posted : September 14, 2016
Information provided by (Responsible Party):
Yea-Ru Yang, National Yang Ming University

Brief Summary:
The purpose of this study was to investigate the effects of virtual reality-base training for cerebellar ataxia.

Condition or disease Intervention/treatment
Cerebellar Ataxia Other: Exergaming training Other: Physical therapy intervention

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 16 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Study Start Date : October 2014
Primary Completion Date : July 2015
Study Completion Date : September 2015

Arm Intervention/treatment
Experimental: Exergaming training
Participants in the exergaming training group received a 4-week exergaming intervention.
Other: Exergaming training
Active Comparator: Control training
Participants in the control training group received a 4-week conventional training.
Other: Physical therapy intervention

Primary Outcome Measures :
  1. Scale for the Assessment and Rating of Ataxia [ Time Frame: Change from baseline at 4 weeks ]
  2. Alternate nose to finger test [ Time Frame: Change from baseline at 4 weeks ]
  3. Alternate heel on shin test [ Time Frame: Change from baseline at 4 weeks ]

Secondary Outcome Measures :
  1. Nine-hole peg test [ Time Frame: Change from baseline at 4 weeks ]
  2. Walking speed [ Time Frame: Change from baseline at 4 weeks ]
  3. Step width [ Time Frame: Change from baseline at 4 weeks ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   20 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • diagnosis of SCA 1, 2, 3 and 6 by a neurologist
  • ability to walk independently with or without any walking aids
  • age ≥ 20
  • a score of ≥ 24 on the mini-mental state examination

Exclusion Criteria:

  • histories of other neurological, cardiovascular, or orthopedic diseases affecting motor performance and balance
  • uncontrolled chronic diseases

Responsible Party: Yea-Ru Yang, Professor, National Yang Ming University
ClinicalTrials.gov Identifier: NCT02900508     History of Changes
Other Study ID Numbers: 201410010A
First Posted: September 14, 2016    Key Record Dates
Last Update Posted: September 14, 2016
Last Verified: September 2016

Additional relevant MeSH terms:
Cerebellar Ataxia
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Cerebellar Diseases
Brain Diseases
Central Nervous System Diseases